Class II

Drug Recall: Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Di

Mckesson Medical-Surgical Inc. Corporate Office · September 11, 2024

Reason for Recall

cGMP Deviations: Temperature excursion

Product Description

Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04

Distribution

Virgina

Quantity Affected

5 cartons/20 units each carton

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0116-2025

Status: terminated

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Mckesson Medical-Surgical Inc. Corporate Office Drug Recall: Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Di | SafeCheck